By Peter Loftus
President Trump's tariffs are eating into profits at GE Healthcare, the large maker of imaging and other medical equipment that was spun out of General Electric in 2023.
GE Healthcare reduced its forecast of full-year 2025 adjusted earnings by about 15% from its prior view, with U.S. and China bilateral tariffs accounting for most of the hit.
Yet, GE Healthcare shares are up about 3% Wednesday because investors already anticipated the tariff impact-trading the stock down year-to-date-and the company is taking actions to mitigate the hit.
The company also reported better-than-expected first-quarter results, analysts said.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
April 30, 2025 11:36 ET (15:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.